Melatonin as an antiaging drug: Between facts and fantasy

Gerontology

Volumn 42, Issue 2, 1996, Pages 87-96

  Huether, Gerald ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Aging; Brain; Immune system; Melatonin; Radical scavenger; Side effects

Indexed keywords

HORMONE; MELATONIN; REACTIVE OXYGEN METABOLITE; SCAVENGER;

AGING; ARTICLE; BRAIN; CELL CULTURE; CIRCADIAN RHYTHM; DIET RESTRICTION; HORMONAL REGULATION; IMMUNE SYSTEM; LONG TERM CARE; PRIORITY JOURNAL; SEASONAL VARIATION; SIGNAL TRANSDUCTION;

EID: 0029875860     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213777     Document Type: Article

References (67)

1. Bock SJ, Boyette M: Stay Young the Melatonin Way. New York, Penguin Books. Dutton Signet. 1995.
2. Lcmcr AB, Case JD, Heinzclman RV: Structure of melatonin. J Am Chem Soc 1959:81:6084-6085.
3. Reiter RJ: The pineal and its hormones in the regulation of reproduction in mammals. Endocr Res 1980: 1:109-131.
4. Reiter RJ: Comparative physiology: Pineal gland. Annu Rev Physiol 1973;35:305-328.
5. Morgan PJ, Williams LM: Central melatonin receptors: Implications for a mode of action. Expcrientia 1989:45:955-965.
6. Armstrong S: Melatonin: The internal zeitgeber of mammals? Pineal Res Rev 1989:7:157-202.
7. Cassone VM, Chesworth MJ, Armstrong SM: Entrainment of rat circadian rhythms by daily injections of melatonin depend upon the hypothalamic suprachiasmatic nuclei. Physiol Behav 1986:36:111-116.
8. Arendt J, Aldhous M, English J, Marks V, Arendt JH, Marks M, Fol-kard S: Some effects of jet lag and their alleviation by melatonin. Ergonomics 1987:30:1379-1385.
9. Reiter RJ: Melatonin: That ubiquitously acting pineal hormone. News Physiol Sci 1991 b;6:223-227.
10. Benitz-King G, Anton-Tay F: Calmodulin mediates melatonin cyto-skeletal effects. Experientia 1993: 49:635-641.
11. Guerrero JM, Lopcz-Gonzalez MA, Osuna C, Calvo JR: Specific binding of melatonin by immunocompetent cells in humans and rodents. Ann NY Acad Sci 1994;719:369-377.
12. Tan DX, Chen DX, Poeggeler B, Manchester EC, Reiter RJ: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr J 1993:1:57-60.
13. Hardeland R, Balzer I, Poeggeler B, Fuhrbcrg B, Uria H, Behrmann G, Wolf R, Meyer TJ, Reiter RJ: On the primary functions of melatonin in evolution: Mediation of photo-periodic signals in a unicell, photooxidation. and scavenging of free radicals. J Pineal Res 1995; 18:104-111.
14. Franchi AM, Gimeno MF, Cardi-nani DP, Valas MJ: Melatonin. 5-methoxytryptamine and some of their analogs as cyclooxygenase inhibitors in rat medial basal hypothalamus. Brain Res 1987:405:384-388.
15. Nir I, Schmidt U, Zilber N: The antigonadotrophic effect of melatonin in Syrian hamsters is modulated by prostaglandin. J Neural Transm [Gen. Sect] 1994:95:173-177.
16. Pozo D, Reiter RJ, Calvo JM, Guerrero JM: Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994;55:PL455-PL460.
17. Barlow-Walden L, Reiter RJ, Abe M, Pablos MI, Menendez-Pelaez A, Chen LD, Poeggeler B: Melatonin stimulates brain glutathione peroxidase activity. Neurochent Int. in press.
18. Huether G, Poeggeler B, Reimcr A. George A: Effect of tryptophan administration on circulating melatonin levels in chicks and rats: Evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992:51:945-953.
19. Huether G: The contribution of ex-trapincal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993:49:665-670.
20. Huether G, Hajak G, Reimer A, Poeggeler B, BImer M, Rodenbeck A, Rüther E: The metabolic fate of infused β-tryptophan in men: Possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology 1992:106:442- 432.
21. Krause DN, Dubocovich ML: Regulatory sites in the melatonin system of mammals. Trends Neurol Sci 1990:13:464-470.
22. Reiter RJ, Craft CM, Johnson JE Jr, King TS, Richardson BA, Vaughan GM, Vaughan MK: Age-associated reduction in nocturnal melatonin levels in female rats. Endocrinology 1981;109:1295-1297.
23. Touitou Y, Fevre M. Lagugvcy M, Carayon A, Boydon A, Reinherl A: Age and mental health related circadian rhyt hrns of plasma levels of melatonin, prolactin, luteinizing hormone and follicle stimulating hormone. J Endocrinol 1981:91:367-375.
24. Hajak G, Rodenbeck A, Bandelow B, Friedrichs S, Huether G, Rüther E: Nocturnal plasma melatonin levels aAer flunitrazepam administration in healthy subjects. Eur Ncu-ropsychopharmacol. in press.
25. Huether G, Poeggeler B, Adler L. Rüther E: Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats. Eur J Pharmacol 1993;238:249-254.
26. Stokkan KA, Reiter RJ, Nonaka KO, Lerchl A, Yu BP. Vaughan MK: Food restriction retards aging of the pineal gland. Brain Res 1991; 545:66-72.
27. Huether G: Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin. Ann NY Acad Sci 1994:719:146-158.
28. Pierpaoli W, Dall'Ara A, Pedrinis E, Regelson W: The pineal control of aging: The effects of melatonin and pineal grafting on the survival of older mice. Ann NY Acad Sci 1991; 621:291-313.
29. Pierpaoli W, Regelson W: Pineal control of aging: Effect of melatonin and pineal grafting in aging mice. Proc Natl Acad Sci USA 1994:91: 787-791.
30. Wu W, Scott ED, Reiter RJ: Transplantation of the mammalian pineal gland: Studies on survival, revascularization. reinncrvation, and recovery of function. Exp Neurol 1993; 122;88-99.
31. Maestroni GJM, Conti A, Pierpaoli KW: Pineal melatonin: Its fundamental immunoregulatory role in aging and cancer. Ann NY Acad Sci 1988:521:140-148.
32. Trcntini GP, De Gacntani C, Cri-scuolo M: Pineal gland and aging. Aging (Milano) 1991:3:103-116.
33. Masoro EJ: Food restriction in rodents: An evaluation of its role in aging. J Gerontol 1988;43:B59-B64.
34. Rose MR: Evolutionary Biology of Aging. Oxford, Oxford University Press, 1991.
35. Chung MH, Rasel H. Nishimura S, Yu BP: Protection against DNA damage by dietary restriction. Free Radic Biol Med 1992;12:523-525.
36. Pieri C, Marra M, Moroni F, Rec-chioni R, Marche-Selli F: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:PL271-PL276.
37. Tan DX, Pocggcler B, Reiter RJ, Chen LD, Chen S, Manchester LC, Barlow-Walden LR: The pineal hormone melatonin inhibits DNA ad-duct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993;70:65-71.
38. Tan DX, Reiter RJ, Chen LD, Pocg-gelcr B, Manchester LC, Barlow-Walden L.R: Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994; 15:215-218.
39. Vijayalaxnti B. Reiter RJ. Meltz ML: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutât Res 1995:346:23-31.
40. Blinkenstaff RT, Brandstadtcr SM, Reddy S, Witt R: Potential radio-protective agents. 1. Homologs of melatonin. J Pharm Sci 1994:83: 216-218.
41. Abc M, Reiter RJ, Orhil PB, Hara M, Poeggeler B: Inhibitory effect of melatonin on cataract formation in newborn rats: Evidence for an antioxidative role for melatonin in rats. Life Sci 1994:56:83-89.
42. Mclchiorri D, Reiter RJ, Attia AM, Hara M, Burgus A, Nistico G: Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1994; 56:83-89.
43. Sewcrynek E, Abe M, Reiter RJ, Barlow-Walden LR, Chen LD, McCabe TJ, Roman LJ, Diaz-Lopez B: Melatonin administration prevents lipopolysaccharidc-induccd oxidative damage in phenobarbital-treated animals. J Cell Biochem. in press.
44. 2+) dependent ATPase in cardiac sarcolem-ma. J Pineal Res 1993:14:178-183.
45. Mcnendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden LR, Pablos MI, Tan DX: Nuclear localization of melatonin in different mammalian tissues: Immunocytochcmi-cal and radioimmunoassay evidence. J Cell Biochem 1993:53:372-382.
46. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC: Melatonin hydroxyl radical mediated oxidative damage and aging: A hypothesis. J Pineal Res 1993; 14:151-168.
47. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995:9: 526-533.
48. Kennaway DJ, Hugel HM: Melatonin binding sites: Are they receptors? Mol Cell Endocrinol 1992;88:C1-C9.
49. Giusti P: Neuroprotective actions of melatonin; in: Allegri Filippinc G, Costa CVL (cds): Recent Advances in Tryptophan Research. New York. Plenum Press, in press.
50. Naranjo-Rodriguez EB, Prieto-Gomez B, Rcycs-Vazqucs C: Melatonin modifies the spontaneous multiunit activity recorded in several brain nuclei of freely behaving rats. Brain Res Bull 1991:27:595-600.
51. uC]-g!ucosc uptake within rat su-prachiasmatic nucleus. Am J Physiol 1988;255:R332-R337.
52. Golombek DA, Femandez-Dugue D, DeBrito-Sanchez MG, Burin L, Cardinali DP: Time-dependent an-ticonvulsive activity of melatonin in hamsters. Eur J Pharmacol 1992: 210:253-258.
53. Rosenstein RE, Cardinali DP: Central gabacrgic mechanisms as targets for melatonin activity in brain. Neu-rochem Int 1990:17:373-379.
54. Dubocovich ML: Pharmacology and function of melatonin receptors. FASEB J 1988;2:2765-2773.
55. Fang JM, Dubocovich ML: Activation of melatonin receptor sites retarded the depletion of norepinephrine following inhibition of synthesis in the C3H/Mcn mouse hypothalamus. J Ncurochem 1990:55: 76-82.
56. Dugovic C, Leyscn JE, Wanquier A: Melatonin modulates the sensitivity of 5-hydroxytryptamine-2-receptor-mcdiated sleep-wakefulncss regulation in the rat. Neurosci Lett 1989; 104:320-325.
57. Migucz J, Martin F, Aldcgunde M: Differential effects of pinealectomy on amygdala and hippocampus serotonin metabolism. J Pineal Res 1991:10:100-103.
58. Trcntini GP, Genazzani AR, Cri-scuolo M: Melatonin treatment delays reproductive aging of female rat via the opiatergic system. Neuroendocrinology 1992;56:364-370.
59. Cassonc VM: Effects of melatonin on vertebrate circadian systems. Trends Neurol Sci 1990; 13:457- 464.
60. Pierpaoli W: The pineal gland: A circadian or seasonal aging clock. Aging (Milano) 1991;3:99-101.
61. Maestroni GJMA, Conti A, Pier-paoli W: The pinal gland and the circadian, opiatergic, immunoregula-tory role of melatonin. Ann NY Acad Sci 1987;496:67-77.
62. Haidar C, Haussier D, Gupta D: The role of the opioids (met-enkeph-alin and beta-endorphin), epithal-amin, melatonin, thymosin and norepinephrine in regulating colony-forming units for granulocytc-maco-phages in bone marrow cell cultures from intact and pinealectomized rats. Biogenic Amines 1992:9:1-6.
63. Blask DE: The Pineal: An Oncostat-ic Gland? In Reiter RJ (ed): The Pineal Gland. New York, Raven Press, 1984, pp 253-284.
64. Reiter RJ: Pineal gland, cellular proliferation and neoplastic growth: A historical account; in Gupta D, Reiter RJ (eds): The Pineal Gland and Cancer. Tübingen, Brain Research Promotions, 1988, pp 41-64.
65. Sze SF, Ng TB, Liu WK: Antiproliferative effect of pineal indoles on cultured tumor cell lines. Pineal Res 1993:14:27-33.
66. Giraldi T, Perissin L, Zorzet S, Ra-pozzi V: Stress, melatonin and tumor progression in mice. Ann NY Acad Sei 1994;719:526-536.
67. Maestroni GJM, Conti A, and Picr-paoli W: Melatonin, stress and the immune system. Pineal Res Rev 1989;7:203-226.